SmartHeart has made it possible for me to study real-time ECG changes in patients with heart disease, without the need for in person research visits. Patients are excited about participating because the SmartHeart is easy to use and gives them immediate feedback.
The cost of care for patients with acute myocardial infarction continues after patients leave the hospital. At-home solutions offer a cost-effective means to manage cardiovascular disease. Telehealth services facilitated by SmartHeart®, the only FDA-cleared, hospital-grade, remote 12-lead ECG, enables substantial cost savings, while improving outcomes and patient satisfaction.
